Eva W. Stratford

1.1k total citations
17 papers, 621 citations indexed

About

Eva W. Stratford is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Eva W. Stratford has authored 17 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Eva W. Stratford's work include Sarcoma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers) and Cancer Cells and Metastasis (4 papers). Eva W. Stratford is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers) and Cancer Cells and Metastasis (4 papers). Eva W. Stratford collaborates with scholars based in Norway, United States and United Kingdom. Eva W. Stratford's co-authors include Ola Myklebost, Else Munthe, Leonardo A. Meza‐Zepeda, Silje U. Lauvrak, Heidi M. Namløs, Stine H. Kresse, Susanne Lorenz, Iwona Grad, Tale Barøy and Magne Skårn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Eva W. Stratford

17 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva W. Stratford Norway 14 413 269 158 150 45 17 621
Kakoli Das Singapore 16 416 1.0× 251 0.9× 170 1.1× 193 1.3× 52 1.2× 26 676
Tzu‐Ju Chen Taiwan 14 342 0.8× 194 0.7× 130 0.8× 163 1.1× 44 1.0× 51 591
Takeshi Niinuma Japan 17 617 1.5× 388 1.4× 132 0.8× 120 0.8× 63 1.4× 39 872
L. Adam United States 9 279 0.7× 106 0.4× 102 0.6× 213 1.4× 20 0.4× 10 544
Katelynn Bill United States 5 251 0.6× 142 0.5× 132 0.8× 91 0.6× 22 0.5× 5 441
Atsushi Yawata Japan 10 353 0.9× 85 0.3× 50 0.3× 131 0.9× 40 0.9× 22 572
Shinichi Umeda Japan 16 356 0.9× 136 0.5× 191 1.2× 186 1.2× 66 1.5× 58 624
Yugang Wen China 14 588 1.4× 340 1.3× 112 0.7× 189 1.3× 43 1.0× 26 783
Jan‐Patrik Wiksten Finland 10 390 0.9× 154 0.6× 101 0.6× 213 1.4× 41 0.9× 10 646
K H Chung Japan 12 166 0.4× 107 0.4× 143 0.9× 249 1.7× 65 1.4× 20 497

Countries citing papers authored by Eva W. Stratford

Since Specialization
Citations

This map shows the geographic impact of Eva W. Stratford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva W. Stratford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva W. Stratford more than expected).

Fields of papers citing papers by Eva W. Stratford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva W. Stratford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva W. Stratford. The network helps show where Eva W. Stratford may publish in the future.

Co-authorship network of co-authors of Eva W. Stratford

This figure shows the co-authorship network connecting the top 25 collaborators of Eva W. Stratford. A scholar is included among the top collaborators of Eva W. Stratford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva W. Stratford. Eva W. Stratford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Munthe, Else, Iwona Grad, Jianhua Han, et al.. (2019). Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma. Cells. 8(2). 189–189. 16 indexed citations
2.
Namløs, Heidi M., Kjetil Boye, Tale Barøy, et al.. (2018). Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 17(11). 2473–2480. 60 indexed citations
3.
Meza‐Zepeda, Leonardo A., et al.. (2018). Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas. International Journal of Molecular Sciences. 19(4). 969–969. 14 indexed citations
4.
Stratford, Eva W., et al.. (2017). Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b. Scientific Reports. 7(1). 9655–9655. 28 indexed citations
5.
Voisset, Edwige, Eva W. Stratford, Robert K. Hills, et al.. (2017). Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. Blood. 131(6). 636–648. 41 indexed citations
6.
Voisset, Edwige, Eva W. Stratford, Robert K. Hills, et al.. (2016). Pml Nuclear Body Disruption Cooperates in APL Pathogenesis, Impacting DNA Damage Repair Pathways. Blood. 128(22). 742–742. 1 indexed citations
7.
Grad, Iwona, Susanne Lorenz, Eva W. Stratford, et al.. (2016). Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma. Oncotarget. 7(34). 54583–54595. 19 indexed citations
8.
Tran, Dat Q., Dolores Diaz, Alireza Torabi, et al.. (2015). Functional Genomics Analysis Reveals a MYC Signature Associated with a Poor Clinical Prognosis in Liposarcomas. American Journal Of Pathology. 185(3). 717–728. 14 indexed citations
9.
Järnum, Sofia, Sameer S. Udhane, Emma Jonasson, et al.. (2015). HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell deathin vitroandin vivo. Oncotarget. 7(1). 433–445. 10 indexed citations
10.
Grad, Iwona, Leonardo A. Meza‐Zepeda, Bernd Thiede, et al.. (2014). Metabolic reprogramming of metastatic breast cancer and melanoma bylet-7amicroRNA. Oncotarget. 6(4). 2451–2465. 66 indexed citations
11.
Lauvrak, Silje U., Else Munthe, Stine H. Kresse, et al.. (2013). Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. British Journal of Cancer. 109(8). 2228–2236. 196 indexed citations
12.
Skårn, Magne, Tale Barøy, Eva W. Stratford, & Ola Myklebost. (2013). Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells. PLoS ONE. 8(11). e79231–e79231. 22 indexed citations
13.
Stratford, Eva W., Monica Bostad, Ellen Skarpen, et al.. (2013). Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(8). 4235–4243. 29 indexed citations
14.
Voisset, Edwige, Eva W. Stratford, Bernd B. Zeisig, et al.. (2013). Disruption Of PML Nuclear Bodies Cooperates In The Pathogenesis Of Acute Promyelocytic Leukemia. Blood. 122(21). 3721–3721. 1 indexed citations
15.
16.
Stratford, Eva W., et al.. (2012). Characterization of Liposarcoma Cell Lines for Preclinical and Biological Studies. Sarcoma. 2012. 1–9. 32 indexed citations
17.
Stratford, Eva W., Ruth Holm, Else Munthe, et al.. (2011). Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential. SHILAP Revista de lepidopterología. 1(1). 8–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kakoli Das Breakdown of academic impact, for papers by Tzu‐Ju Chen Breakdown of academic impact, for papers by Takeshi Niinuma Breakdown of academic impact, for papers by L. Adam Breakdown of academic impact, for papers by Katelynn Bill Breakdown of academic impact, for papers by Atsushi Yawata Breakdown of academic impact, for papers by Shinichi Umeda Breakdown of academic impact, for papers by Yugang Wen Breakdown of academic impact, for papers by Jan‐Patrik Wiksten Breakdown of academic impact, for papers by K H Chung
Rankless by CCL
2026